Financial Performance - The company's revenue for 2024 was CNY 1,380,254,020.51, a decrease of 15.71% compared to CNY 1,637,567,748.39 in 2023[16]. - Net profit attributable to shareholders for 2024 was CNY 46,719,608.82, down 33.60% from CNY 70,364,740.74 in 2023[16]. - The net profit after deducting non-recurring gains and losses was CNY 45,983,843.85, a decrease of 29.50% from CNY 65,229,683.42 in 2023[16]. - Basic earnings per share for 2024 were CNY 0.18, a decline of 30.77% compared to CNY 0.26 in 2023[16]. - Total assets at the end of 2024 were CNY 1,103,346,118.01, a decrease of 13.40% from CNY 1,274,031,659.57 at the end of 2023[16]. - Net assets attributable to shareholders increased by 1.66% to CNY 823,338,897.82 from CNY 809,886,297.25 at the end of 2023[16]. - The revenue from daily chemical products was CNY 402,760,889.45, representing 29.18% of total revenue, a decline of 14.31% from the previous year[36]. - Revenue from the online gaming segment was CNY 973,204,805.49, accounting for 70.51% of total revenue, down 16.40% year-on-year[36]. Cash Flow and Investments - Operating cash flow net amount increased by 138.45% to CNY 165,276,242.39 from CNY 69,314,099.52 in 2023[16]. - The net cash flow from operating activities in Q4 2023 was approximately CNY 108.60 million, a substantial increase compared to a negative cash flow of approximately CNY 30.95 million in Q1 2023[20]. - Total cash inflow from operating activities decreased by 18.56% to ¥1,248,071,078.58 in 2024, while cash outflow decreased by 26.00% to ¥1,082,794,836.19[51]. - Net cash flow from investment activities dropped significantly by 774.88% to -¥105,659,688.83, mainly due to the purchase of financial products[53]. - Cash and cash equivalents increased by only ¥2,474,448.11 in 2024, a decline of 91.90% compared to the previous year[52]. Business Strategy and Market Position - The company has shifted its business model to include both daily chemical products and online gaming, indicating a strategic expansion[14]. - The company is focusing on diversifying sales channels, including e-commerce and live streaming, to enhance market competitiveness and mitigate risks associated with single-channel operations[26]. - The company plans to invest in new product development and technology to meet the increasing demand for personalized and high-quality daily chemical products[27]. - The company is currently developing three major projects aimed at transforming and expanding its product lines, with positive impacts expected on future revenue[46]. - The company will focus on developing high-quality games and improving product longevity, with plans to enter new overseas markets in 2024[72]. Research and Development - The number of R&D personnel decreased by 57.97% from 345 in 2023 to 145 in 2024, with a corresponding drop in the proportion of R&D personnel from 22.26% to 11.44%[49]. - R&D investment amounted to ¥69,410,518.02 in 2024, a decrease of 37.62% compared to ¥111,267,763.02 in 2023, with the R&D investment as a percentage of operating revenue falling from 6.79% to 5.03%[49]. - The company holds 56 invention patents and has established itself as a leader in domestic daily chemical product technology[32]. - The company has a total of 117 copyright registrations in its gaming business, indicating strong intellectual property assets[33]. Governance and Shareholder Relations - The company has established a governance structure that ensures equal rights for all shareholders, particularly minority shareholders, in decision-making processes[81]. - The company emphasizes the importance of brand reputation and will actively monitor and protect its brand against infringement[74]. - The company has maintained a clear and transparent cash dividend policy, ensuring the protection of minority shareholders' rights[111]. - The annual shareholder meeting had a participation rate of 40.63%, with all proposed resolutions approved[87]. - The company has appointed independent directors to ensure compliance and oversight, with specific roles in various committees[94]. Subsidiaries and Market Expansion - The company established five new subsidiaries during the reporting period, including Hallgou Network Technology Co., Ltd. and Guangxi Tianniu Information Technology Co., Ltd.[42]. - The subsidiary Guangdong Mingchen Daily Chemical Co., Ltd. reported revenue of ¥405,131,496.53 and a net profit of ¥14,261,604.75 during the reporting period[66]. - The subsidiary Hainan Xingxuan Shikong Network Technology Co., Ltd. achieved revenue of ¥771,054,905.78 and a net profit of ¥108,126,314.63 in the reporting period[70]. Risk Management - The company acknowledges potential risks in its future operations as outlined in the management discussion section[4]. - The company is aware of risks related to brand image and competition in the gaming industry, and it has strategies in place to mitigate these risks[76]. Social Responsibility and Community Engagement - The company sponsored 150,000 yuan for a traditional cultural event and donated 120,000 yuan for a calligraphy competition, supporting cultural heritage and education[127]. - The company emphasizes a "people-oriented" approach, providing training and development opportunities for employees to enhance their skills[124]. Compliance and Internal Controls - The company has established a comprehensive internal control system that has been effectively implemented, with no significant defects identified in financial reporting[114]. - The internal control audit report indicates that the company maintained effective financial reporting internal controls as of December 31, 2024[119]. - The company has not identified any significant defects in internal controls related to non-financial reporting during the evaluation period[117].

证券代码：002919 证券简称：名臣健康 公告编号：2025-006 名臣健康用品股份有限公司 关于 2024 年度利润分配预案的公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚 假记载、误导性陈述或重大遗漏。 一、审议程序 名臣健康用品股份有限公司（以下简称"公司"）于 2025 年 4 月 28 日召开 了第四届董事会第四次会议和第四届监事会第四次会议，审议通过了《关于<2024 年度利润分配预案>的议案》，本议案尚需提交公司 2024 年年度股东大会审议。 现将有关情况公告如下： 二、利润分配预案基本情况 1、年度现金分红方案相关指标 根据致同会计师事务所（特殊普通合伙）出具的《名臣健康用品股份有限公 司 2024 年度审计报告》（致同审字（2025）第 351A020765 号）显示，公司 2024 年实现归属母公司股东的净利润 46,719,608.82 元，母公司实现净利润为亏损 5,048,236.04 元。根据《公司法》和《公司章程》等相关规定，2024 年母公司 不提取法定盈余公积金，截至 2024 年 12 月 31 日，公司合并口径可供股东分配 的利润为 354, ...

注：本次质押股份未负担重大资产重组等业绩补偿义务。 名臣健康用品股份有限公司关于控股股东部分股份质押的公告 登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码：002919 证券简称：名臣健康 公告编号：2025-001 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚假记载、误导性陈述或重大遗 漏。 名臣健康用品股份有限公司（以下简称"公司"）近日收到公司控股股东陈勤发先生的告知函，获悉陈勤 发先生将其所持公司部分股份办理了质押手续，具体事项如下： 一、股东股份质押基本情况 ■ 三、备查文件 1、证券质押登记证明； 2、中国证券登记结算有限责任公司证券质押明细表； 3、告知函。 二、股东股份累计质押的基本情况 截至本公告披露日, 陈勤发先生所持质押股份情况： ■ 注：上表中若出现总计数与所列数值总和不符，均为四舍五入所致。 截至本公告披露日，陈勤发先生持有公司93,338,604股股份，占公司总股本的35.02%，其中累计质押的 股份数为11,644,000股，占其持有公司股份总数的12.48%，占公司总股本的4.37%。陈勤发先生累计质 押股份不存在被强制平仓风险，亦不会对公司生产 ...

一、股东股份质押基本情况 证券代码：002919 证券简称：名臣健康 公告编号：2025-001 名臣健康用品股份有限公司 关于控股股东部分股份质押的公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚 假记载、误导性陈述或重大遗漏。 名臣健康用品股份有限公司（以下简称"公司"）近日收到公司控股股东陈 勤发先生的告知函，获悉陈勤发先生将其所持公司部分股份办理了质押手续，具 体事项如下： | 股东 | 是否为控股 | | | | | 是否 | | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | | 股东或第一 | 本次质押股 | 占其所 持股份 | 占公司 总股本 | 是否 为限 | 为补 | 质押起始 | | 质押到 | 质权 | 质押 | | 名称 | 大股东及其 | 份数量（股） | 比例 | 比例 | 售股 | 充质 | 日 | | 期日 | 人 | 用途 | | | 一致行动人 | | | | | 押 | | | | | | | 陈勤 | | | | | | | 2 ...

证券代码：002919 证券简称：名臣健康 公告编号：2024-039 名臣健康用品股份有限公司 关于设立全资孙公司的进展公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚 假记载、误导性陈述或重大遗漏。 名臣健康用品股份有限公司（以下简称"公司"）于2024年10月29日召开了 公司第四届董事会第三次会议，审议通过了《关于全资子公司拟投资设立孙公司 的议案》，同意公司子公司广东名臣日化有限公司拟投资500万元在广州独资设立 孙公司名臣日化电子商务有限公司（暂定名）（以下简称"孙公司"）。具体内 容详见公司于2024年10月30日在《证券日报》、《证券时报》、《中国证券报》、《上 海证券报》和巨潮资讯网（www.cninfo.com.cn）披露的《第四届董事会第三次 会议决议公告》（公告编号：2024-036）。 近日，孙公司完成了工商登记手续并取得由广州市白云区市场监督管理局正 式核准颁发的《营业执照》，具体信息如下： 1、公司名称：广州名臣智易网络有限公司 7、成立日期：2024 年 11 月 19 日 8、营业期限：长期 9、经营范围：互联网数据服务；技术进出口；货物进出口；化妆品零 ...

本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚 假记载、误导性陈述或重大遗漏。 名臣健康用品股份有限公司（以下简称"公司"）于近日接到持股 5%以上 股东吴心玲女士的通知，获悉吴心玲女士将其所持有的部分公司股份办理了补充 质押，具体事项如下： | 股东名称 | 是否为控股 股东或第一 | 本次质押股 | 占其所 | 占公司 | 是否 | 是否 为补 | | 质押到 | | 质押用 | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | | | | 持股份 | 总股本 | 为限 | | 质押起始 | | 质权人 | | | | 大股东及其 | 份数量（股） | | | | 充质 | | 期日 | | 途 | | | | | 比例 | 比例 | 售股 | | | | | | | | 一致行动人 | | | | | 押 | | | | | | | | | | | | | 2024 年 11 | 解除质 | 招商证券 | 补充质 | | 吴心玲 | 否 | 1,280,000 | 8.73% | 0.48% | ...

名臣健康用品股份有限公司(以下简称"公司")第四届董事会第三次会议于 2024年10月29日在公司子公司喀什奥术网络科技有限公司会议室以现场方式召 开，会议通知以专人送达、传真、电子邮件、电话相结合的方式已于2024年10 月25日向各位董事发出。本次会议由董事陈建名先生主持。本次会议应出席董事 7名，实际出席董事7名，公司监事列席会议。本次会议的召开符合《公司法》、 《公司章程》等法律法规的规定，合法有效。 二、董事会会议审议情况 1、审议通过《关于<2024 年第三季度报告>的议案》 名臣健康用品股份有限公司 第四届董事会第三次会议决议公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚 假记载、误导性陈述或重大遗漏。 一、董事会会议召开情况 证券代码：002919 证券简称：名臣健康 公告编号：2024-036 表决结果：有效表决 7 票，同意票 7 票，反对票 0 票，弃权票 0 票。 经审核，董事会认为，公司 2024 年第三季度报告的内容真实、准确、完整 地反映了公司 2024 年第三季度经营的实际情况，不存在任何虚假记载、误导性 陈述或重大遗漏。 具体内容详见公司在《证券日报》 ...

证券代码：002919 证券简称：名臣健康 | --- | --- | --- | |-----------------------|-------------------------------------------|-------------------------------------------------------------------------------------| | | | | | | □特定对象调研 | □分析师会议 | | | | □媒体采访 □业绩说明会 | | 投资者关系活动 | □新闻发布会 | □路演活动 | | 类别 | □现场参观 | | | | 其他（ 2024 | 广东辖区上市公司投资者集体接待日） | | 参与单位名称 | 投资者网上提问 | | | 时间 | 2024年9月12日15:30-16:30 | | | 方式 | | 公司通过全景网"投资者关系互动平台" (https://ir.p5w.net) | | | | 采用网络远程的方式召开业绩说明会 | | 上市公司接待人 员姓名 | 公司董事长、总经理陈建名 | 公司副董事长、副总经理、财务总监彭小 ...

证券代码：002919 证券简称：名臣健康 公告编号：2024-035 名臣健康用品股份有限公司 关于参加广东辖区 2024 年投资者 网上集体接待日活动的公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚 假记载、误导性陈述或重大遗漏。 为进一步加强与投资者的互动交流，名臣健康用品股份有限公司（以下简称 "公司"）将参加由广东证监局、广东上市公司协会联合举办的"坚定信心 携 手共进 助力上市公司提升投资价值——2024 广东辖区上市公司投资者关系管 理月活动投资者集体接待日"，现将相关事项公告如下： 本次活动将采用网络远程的方式举行，投资者可以登录"全景路演"网站 （http://rs.p5w.net）参与本次互动交流，活动时间为 2024 年 9 月 12 日（星 期四）15:30-16:30。 届时公司部分高管将在线就公司业绩、公司治理、发展战略、经营状况和可 持续发展等投资者关心的问题，与投资者进行沟通与交流，欢迎广大投资者踊跃 参与。 特此公告。 名臣健康用品股份有限公司 董事会 二〇二四年九月十一日 ...

Financial Performance - The company's operating revenue for the first half of 2024 was CNY 664,655,853.45, a decrease of 21.30% compared to CNY 844,585,892.73 in the same period last year[11]. - The net profit attributable to shareholders for the first half of 2024 was CNY 60,362,924.24, down 39.42% from CNY 99,642,930.15 in the previous year[11]. - The net profit after deducting non-recurring gains and losses was CNY 58,611,063.11, a decline of 40.69% compared to CNY 98,825,203.27 in the same period last year[11]. - The basic earnings per share for the first half of 2024 was CNY 0.23, down 37.84% from CNY 0.37 in the same period last year[11]. - The company's total revenue for the reporting period was ¥664,655,853.45, representing a decrease of 21.30% compared to ¥844,585,892.73 in the same period last year[24]. - The operating profit for the first half of 2024 was CNY 66,546,440.80, a decline of 18.2% compared to CNY 81,453,165.85 in the first half of 2023[82]. - Net profit for the first half of 2024 was CNY 65,236,046.38, down from CNY 81,398,181.13 in the same period of 2023[82]. - Total comprehensive income for the period was CNY 60.36 million, compared to CNY 99.64 million in the previous year, reflecting a decline of 39.4%[83]. Cash Flow and Assets - The net cash flow from operating activities improved significantly to CNY 32,532,543.64, compared to a negative cash flow of CNY -37,581,328.74 in the previous year, marking an increase of 186.57%[11]. - Cash and cash equivalents decreased by 26.60% to ¥129,129,509.67 from ¥169,035,036.07 at the end of the previous year[28]. - The total assets as of June 30, 2024, were CNY 1,212,666,800.48, a decrease of 4.82% from CNY 1,274,031,659.57 at the end of the previous year[11]. - Current assets totaled CNY 841,664,790.11, down from CNY 857,578,943.98, indicating a decrease of about 1.8%[75]. - The total cash balance at the end of the period amounted to CNY 129,129,509.67, compared to CNY 169,035,036.07 at the beginning[196]. Business Operations - The company operates under a dual main business model, focusing on both daily chemical products and online gaming since the acquisition of Hainan Huaduo in August 2020[14]. - The daily chemical business includes major brands such as Tihua Zhi Xiu and Mei Wang, offering products like shampoos and skincare items aimed at providing high cost-performance[15]. - The gaming business has developed popular titles such as "Kingdom of Kings" and "Zhenhun Street: Born to be King," with a focus on content-rich games across various genres[15]. - The company has established four wholly-owned subsidiaries for game development and publishing, enhancing its operational flexibility and market presence[14]. - The gaming revenue model primarily relies on the sale of virtual items, with plans to expand through licensing and joint operations for game publishing[16]. Research and Development - Research and development expenses were reduced by 39.71% to ¥38,069,021.81 from ¥63,139,913.44, attributed to project optimization and team consolidation[24]. - The company holds 1,138 independent intellectual property trademarks, 56 technology inventions, and 89 design patents, showcasing its strong R&D capabilities[21]. - The gaming segment has developed 112 copyrights, with key projects including "Wang Zhe Guo Du" and "Jing·Jie Dao Ming" currently in focus[22]. Shareholder and Governance - The company plans not to distribute cash dividends or issue bonus shares for the reporting period[1]. - The annual shareholders' meeting had a participation rate of 40.63% and all resolutions were approved on May 20, 2024[39]. - The company approved a cash dividend of RMB 1.5 per 10 shares, totaling RMB 33,267,008.25, and a capital reserve conversion of 44,356,011 shares, increasing total shares to 266,526,066[60]. - The company’s governance structure was updated with the election of a new chairman and vice-chairman[60]. Market and Competition - The company faces risks related to brand image infringement, which could negatively impact its operations and financial performance[35]. - The company is aware of competition risks in the gaming industry and is strategizing to address these challenges[36]. - The company faces intense competition in the online gaming market, with risks of player retention and revenue delays due to reliance on external IPs[37]. Financial Management - The company has a well-established management system and efficient processes, contributing to its operational effectiveness[23]. - The company emphasizes investor rights protection and has implemented a cash dividend policy for 2023, which was executed in May 2024[43]. - The company has maintained good relationships with suppliers and customers, ensuring contract compliance and product quality[44]. Compliance and Reporting - The company’s financial statements are prepared in accordance with the accounting standards issued by the Ministry of Finance, ensuring compliance and transparency[104]. - The company recognizes revenue when the customer obtains control of the goods or services, which occurs upon fulfilling the performance obligations in the contract[171]. - The company ensures consistent treatment of similar government grants in its financial reporting[176].